Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 24, Issue 4, Pages 650-655Publisher
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2005.03.6095
Keywords
-
Categories
Ask authors/readers for more resources
Purpose To evaluate the rate of pathologic complete response and toxicity of neoadjuvant chemoradiation for advanced T3/74 distal rectal cancers in a randomized phase II study Patients and Methods Patients with clinical T3/T4 distal rectal cancers were randomly assigned in a phase 11 study to receive combined neoadjuvant chemoradiotherapy followed by surgical resection. Patients were randomly assigned to receive continuous venous infusion (CVI) fluorouracil (FU) 225 mg/m(2) per day, 7 days per week, plus pelvic hyperfractionated radiation 55.2 to 60 Gy at 1.2 Gy bid (arm 1) or CVI FU 225 mg/m(2) per day Monday to Friday, 120 hours per week plus irinotecan 50 mg/m(2) once weekly for 4 weeks plus pelvic radiation therapy 50.4 to 54 Gy at 1.8 Gy per day (arm 2). Surgery was performed 4 to 10 weeks after completion of necadjuvant therapy. The primary end point of this study was pathologic complete response (pCR). Secondary end points included acute and late normal tissue morbidity. Results A total of 106 patients were entered onto the study, with 103 assessable for response. The overall resectability rate was 93%. The median time to surgery was 7 weeks. Tumor downstaging was observed in 78% of patients in both arms. The pCR rate for all assessable patients was 26% in each arm. For patients who had surgery, the pCR rate was also the same (28%) in both arms. Acute and late toxicity was also similar. Grade 3 and 4 acute hematologic and nonhematologic toxicity occurred in 13% and 38% in arm 1 and 12% and 45% in arm 2, respectively. Conclusion Although the overall complete response rate and toxicity seems similar in both arms, this is the first multi-institutional study to establish a relatively high (28%) pCR rate after neoadjuvant therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available